SEC Form 4 · accession 0001209191-18-005821
CHIMERIX INC · CMRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Garrett Nichols
Officer — Chief Medical Officer
Period of report
Jan 25, 2018
Accepted (ET)
Jan 29, 2018 · 3:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001117480
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $4.68 | Jan 25, 2018 | A | 148,500 | A | — | Jan 24, 2028 | Common Stock | 148,500 | 148,500 | D |
Explanation of responses
- F11/48th of the shares subject to the option vest in equal monthly installments over a four year period following the date of grant.